Edap Tms SA (NASDAQ:EDAP) was the recipient of a large increase in short interest in September. As of September 30th, there was short interest totalling 51,900 shares, an increase of 30.1% from the August 30th total of 39,900 shares. Based on an average trading volume of 191,400 shares, the short-interest ratio is currently 0.3 days. Approximately 0.2% of the shares of the company are short sold.
Several equities analysts have commented on the company. ValuEngine cut Edap Tms from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Zacks Investment Research raised Edap Tms from a “hold” rating to a “strong-buy” rating and set a $4.25 price target for the company in a report on Friday, September 6th. HC Wainwright set a $7.00 price target on Edap Tms and gave the company a “buy” rating in a report on Friday, August 30th. Finally, TheStreet cut Edap Tms from a “b-” rating to a “d+” rating in a report on Monday, June 17th.
Shares of EDAP traded down $0.10 during mid-day trading on Monday, reaching $4.52. The company had a trading volume of 154,020 shares, compared to its average volume of 180,480. Edap Tms has a twelve month low of $1.35 and a twelve month high of $5.42. The company’s 50-day moving average is $4.06 and its 200-day moving average is $3.61. The company has a market capitalization of $132.81 million, a P/E ratio of 226.00 and a beta of 1.88.
Institutional investors and hedge funds have recently modified their holdings of the company. Hilton Capital Management LLC acquired a new position in shares of Edap Tms in the 1st quarter worth approximately $75,000. JPMorgan Chase & Co. acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $282,000. Susquehanna International Group LLP raised its holdings in shares of Edap Tms by 762.9% in the 2nd quarter. Susquehanna International Group LLP now owns 205,178 shares of the medical equipment provider’s stock worth $556,000 after buying an additional 181,401 shares in the last quarter. Acadian Asset Management LLC acquired a new position in shares of Edap Tms in the 2nd quarter worth approximately $607,000. Finally, Morgan Stanley raised its holdings in shares of Edap Tms by 222.7% in the 2nd quarter. Morgan Stanley now owns 267,408 shares of the medical equipment provider’s stock worth $722,000 after buying an additional 184,539 shares in the last quarter. 13.24% of the stock is owned by institutional investors and hedge funds.
Edap Tms Company Profile
EDAP TMS SA, together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally-invasive medical devices for the treatment of urological diseases worldwide. The company operates in two divisions: High Intensity Focused Ultrasound (HIFU), and Urology Devices and Services (UDS).
Further Reading: How to start trading in the forex market?
Receive News & Ratings for Edap Tms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Edap Tms and related companies with MarketBeat.com's FREE daily email newsletter.